| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.8 |
| mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.8 |
| mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.9 |
| mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.9 |
| mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.9 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
| mRNA |
JW-7-24-1 |
GDSC1000 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.0065 |
0.9 |
| mRNA |
embelin |
GDSC1000 |
pan-cancer |
AAC |
0.006 |
0.9 |